Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Canada
Pneumococcal disease
2023
Americas
Clear all
Type of publications
NITAG documentation
(3)
Topics
Available to download in languages
Regions
Americas
(3)
Countries
Canada
(3)
Diseases
Pneumococcal disease
(3)
COVID-19
(5)
Influenza
(1)
Meningococcal disease
(1)
Vaccine topics
Target population
Adults
(1)
Newborn
(1)
Older adults
(1)
Publication date
2023
(3)
2024
(2)
2022
(2)
2015
(1)
2014
(1)
2010
(1)
2008
(1)
3 results found
2023
∙
NACI
Recommendations on the use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults: Economic evidence supplementary appendix
2023
∙
NACI
Public health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines
2023
∙
NACI
Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register